New Mexico reports two deaths from ivermectin

New Mexico has linked two deaths in the state to misuse of ivermectin, a medicine typically used for parasitic infections in animals that has repeatedly been used by people as an anti-COVID-19 medication. New Mexico reported the two deaths on…

Takeda’s Alofisel (darvadstrocel) Receives MHLW’s Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD

Shots: The approval is based on the two trials i.e., P-III Darvadstrocel-3002 & ADMIRE-CD trial evaluating the safety & efficacy of Alofisel in 22 & 212 patients with CPF with non-active/mildly active luminal CD The results from the P-III ADMIRE-CD trial showed that the proportion of patients in Alofisel over the control group achieved 1EPs …

Takeda’s Alofisel (darvadstrocel) Receives MHLW’s Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD Read More »

Treatment for all: the key steps to better representation in pharma

As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. This already significant industry …

Treatment for all: the key steps to better representation in pharma Read More »

Who won the INVEST Digital Health Pitch Perfect contest?

Judges proclaimed winners across three tracks of the digital health startup pitch contest including: Home health, chronic disease management and value-based care, and technology to support payer and provider efficiency.

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Takeda has chalked up another milestone for its Alofisel cell therapy for a complication of Crohn’s disease, becoming the first allogeneic stem cell therapy to be approved in Japan. Alofisel (darvadstrocel) has been cleared by the Ministry of Health, Labour and Welfare (MHLW) for the treatment of complex perianal fistulas in patients with non-active or …

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel Read More »

Astellas and Seagen’s Padcev (enfortumab vedotin) Receive MHLW’s Approval for the Treatment of Radically Unresectable Urothelial Carcinoma

Shots: The approval is based on the P-III EV-301 clinical trial evaluating Padcev vs CT in 608 patients with LA/mUC prior treated with Pt-based CT and a PD-1/L1 inhibitor The pre-specified interim analysis showed that patients treated with Padcev demonstrated an m-OS (12.9 vs 9.0mos.) with a median of 3.9mos. longer than those who received …

Astellas and Seagen’s Padcev (enfortumab vedotin) Receive MHLW’s Approval for the Treatment of Radically Unresectable Urothelial Carcinoma Read More »

England’s cancer therapy backlog ‘could take more than a decade to shift’

A new report has suggested it could take until 2033 to clear the backlog of cancer treatment in England caused by the pandemic. The analysis by the Institute for Public Policy Research (IPPR) and Carnall Farrar (CF) consultancy suggests that timeline will be the result if hospitals can operate at a level 5% above what …

England’s cancer therapy backlog ‘could take more than a decade to shift’ Read More »

YonaLink, TrialJectory get $1m grant for patient recruitment tool

Two digital health companies – YonaLink and TrialJectory – have received a grant to develop a tool designed to make it easier and quicker to enrol patients into clinical trials. The grant from the Israel-US Binational Industrial Research and Development (BIRD) Foundation will go towards the further development of the platform, which automates the conduct …

YonaLink, TrialJectory get $1m grant for patient recruitment tool Read More »

These Schools Use Weekly Testing to Keep Kids in Class — And Covid Out

On a recent Monday morning, a group of preschoolers filed into the gymnasium at Hillside School in the west Chicago suburbs. These 4- and 5-year-olds were the first of more than 200 students to get tested for the coronavirus that day — and every Monday — for the foreseeable future. At the front of the …

These Schools Use Weekly Testing to Keep Kids in Class — And Covid Out Read More »

Firefighters on Front Lines, No Strangers to Risk, Push Back Against Covid Vaccine Mandates

Kentucky firefighter Jimmy Adams saw the ravages of the coronavirus pandemic when he served as a medic who helped care for the sick on medical calls amid surging covid cases. He knew retired firefighters who died of complications from covid-19. But he reasoned that they were older and likely had underlying health issues, making them …

Firefighters on Front Lines, No Strangers to Risk, Push Back Against Covid Vaccine Mandates Read More »

Who Qualifies for a Covid Booster? The List Is Growing Longer

On Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of coronavirus infection qualify for a shot to boost the protection of their covid-19 vaccination. That step to include people with “institutional and occupational exposure” overrules the recommendation of her agency’s advisory panel, and the move …

Who Qualifies for a Covid Booster? The List Is Growing Longer Read More »

Capricor preps phase 3 for Duchenne cell therapy as it seeks a partner

Capricor Therapeutics’ bid to find a partner for its Duchenne muscular dystrophy (DMD) cell therapy CAP-1002 could get a boost after final phase 2 data showed a strong effect on disease progression. Initial results from the 20-patient HOPE-2 trial reported last year showed signs of activity in older boys and young men with advanced DMD, …

Capricor preps phase 3 for Duchenne cell therapy as it seeks a partner Read More »

Patient Testimonial | Helina Berhe Underwent Breast Lift Surgery in Medicana Camlica Hospital, Turkey

Introduction A young, 35-year-old woman from Ethiopia, Helina Berhe, was looking forward to getting a Breast Lift or Mastopexy for some time. She went online to look for resources and the options available for her. This was when she found MediGence, one of the foremost medical travel organizations. She soon started her consultations with Dr. …

Patient Testimonial | Helina Berhe Underwent Breast Lift Surgery in Medicana Camlica Hospital, Turkey Read More »

JW Reports One-Year Follow-Up Results of Relmacabtagene Autoleucel in P-II RELIANCE Study for the Treatment of R/R LBCL at CSCO 2021

Shots: The P-II RELIANCE study evaluates relma-cel in 59 patients with r/r LBCL who had failed 2L of therapy, including CD20 agent, anthracycline & patients continue to be monitored for ≥2yrs. for LTO As of Dec 31, 2020 cut-off data, Relma-cel showed durable responses & survival benefit; ORR (77.6%); CR rate (51.7%) & 1yrs. OS …

JW Reports One-Year Follow-Up Results of Relmacabtagene Autoleucel in P-II RELIANCE Study for the Treatment of R/R LBCL at CSCO 2021 Read More »

Innovent and AnHeart Report Interim Results of Taletrectinib (AB-106) in P-II TRUST Trial for the Treatment of ROS1-Positive NSCLC at CSCO 2021

Shots: The P-II TRUST trial evaluates taletrectinib (AB-106, ROS1/NTRK inhibitor) in 37 TKI-naïve or pre-treated patients with ROS1-positive NSCLC As of June 16, 2021 cut off data, the therapy demonstrated an ORR (90.5% & 43.8%) & DCR (90.5% & 75.0%) in treatment-naïve & pre-treated patient. ROS1 G2032R resistant mutations were observed in three pre-treated patients …

Innovent and AnHeart Report Interim Results of Taletrectinib (AB-106) in P-II TRUST Trial for the Treatment of ROS1-Positive NSCLC at CSCO 2021 Read More »

Amgen’s Repatha (evolocumab) Receives the US FDA’s Approval for the Treatment of Heterozygous Familial Hypercholesterolemia

Shots: The approval is based on the P-IIIb HAUSER-RCT study evaluating the safety & efficacy of Repatha (420mg, SC) vs PBO in a ratio (2:1) in pediatric patients aged 10 – 17yrs. with HeFH for 24wks. The trial met its 1EPs i.e., 38% reduction in LDL-C from baseline, patients treated with Repatha had improved secondary …

Amgen’s Repatha (evolocumab) Receives the US FDA’s Approval for the Treatment of Heterozygous Familial Hypercholesterolemia Read More »

CVC Files Reply to ToolGen Opposition to CVC Preliminary Motion No. 1

By Kevin E. Noonan — On May 20th, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, “CVC”) filed its Substantive Preliminary Motion No. 1 in Interference No. 106,127 (which names ToolGen as Senior Party), asking the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board for benefit …

CVC Files Reply to ToolGen Opposition to CVC Preliminary Motion No. 1 Read More »

Conference & CLE Calendar

September 27, 2021 – “Interplay Between FDA Law and Patent Law: Avoiding Indigestion After Belcher v. Hospira” (Schwegman Lundberg & Woessner) – 12:00 pm to 1:30 pm (CT) September 28, 2021 – “Inventorship and Assignment: Two Vital Concepts in Patent Law” (Schwegman Lundberg & Woessner) – 12:00 pm (CT) September 28, 2021 – “Mediation Programs …

Conference & CLE Calendar Read More »

Medlius Pharma -Openings for Freshers & Experienced for Multiple Positions-Apply Now

Medlius Pharma -Openings for Freshers & Experienced for Multiple Positions-Apply Now Job Description Designation: National Sales Manager/ Area Sales Manager/ Management Trainee/ Business Executive/ Territory Manager Qualification: B.Pharm/ M.Pharm/ D.Pharm/ B.Sc/ M.Sc/ MBA/ PGDBM Experience: 0-3 years Job Location: Pune/ Thane Interested candidates please share updated resume on hrexecutive@medliuspharma.com  / hr@medliuspharma.com Medlius Pharma -Openings for Freshers & Experienced for Multiple Positions-Apply Now

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for Analytical R&D Department On 3rd October 2021

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for Analytical R&D Department On 3rd October 2021 Job Description Dear Candidate, Walk-In Drive On 3rd October 2021 For Analytical R&D Department  (PDMO & CRO) @ Chemveda Life Sciences, Hyderabad Department: Analytical R&D Designation: Research Associate/  Senior Research Associate Qualification: M.Sc. (Analytical Chemistry/ Organic chemistry) Experience: 3-9 years Division: Synthesis Work Location: Hyderabad Key …

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for Analytical R&D Department On 3rd October 2021 Read More »

WHO looks to revive probe into COVID-19 origins: report

The World Health Organization (WHO) is looking to revive a probe into the origins of the COVID-19 virus, assembling a team of 20 scientists to hunt for new evidence, the Wall Street Journal reported. The new probe comes after an…

Oak Street Health’s CMO Touts Home-Based Care Credentials, New AARP Partnership

On the heels of a new partnership with AARP, Oak Street Health Inc. (NYSE: OSH) has affirmed its commitment to delivering care in the home setting. Founded in 2012, Chicago-based Oak Street Health is a network of value-based primary care centers for adults on Medicare. The company currently operates more than 100 centers across 15 …

Oak Street Health’s CMO Touts Home-Based Care Credentials, New AARP Partnership Read More »

Future Leader: Kris Novak, Amedisys Vice President of Mergers and Acquisitions

The Future Leaders Awards program is brought to you in partnership with PointClickCare. The program is designed to recognize up-and-coming industry members who are shaping the next decade of senior housing, skilled nursing, home health and hospice care. To see this year’s future leaders, visit https://futureleaders.agingmedia.com/. Kris Novak, vice president of mergers and acquisitions at …

Future Leader: Kris Novak, Amedisys Vice President of Mergers and Acquisitions Read More »

‘We’re Never Going Back to an Institution-First Model’: Home Care Veteran Ready to Lead New Aging-in-Place SPAC

A new blank-check company is hunting for aging-in-place businesses to take public. And unlike other senior care-related special purpose acquisition companies (SPACs) launched in the past year, this one — DTRT Health — is led by a well-known home care veteran with ample public experience. “There’s quite a number of fascinating public-ready companies of scale, …

‘We’re Never Going Back to an Institution-First Model’: Home Care Veteran Ready to Lead New Aging-in-Place SPAC Read More »

Mass brawls reported as pandemic restrictions are lifted in Norway

Dozens of violent disturbances took place in Norway on Sunday amid celebrations that followed the government’s abrupt removal of all COVID-19 restrictions.On Friday, Norway announced that all restrictions from the pandemic would be lifted…

Rumour mill says Acceleron is speeding towards $11bn sale

US biopharma company Acceleron is the next company heading for a takeover by a big pharma group – according to a Bloomberg report citing people close to the matter. Rumours of a deal have been bubbling away for a few days, driving Acceleron’s stock upwards, even before Bloomberg reported that a large pharma group is …

Rumour mill says Acceleron is speeding towards $11bn sale Read More »

UK pharmacies in dark about ministers’ plan to maintain drug supplies

Chemists wait for details of measures to ensure driver shortages do not adversely affect deliveries of prescription drugs Pharmacists are waiting for details from the government about what measures are in place to deal with any delays to deliveries of drug supplies as a result of van driver shortages. If the situation worsens, pharmacists have …

UK pharmacies in dark about ministers’ plan to maintain drug supplies Read More »

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters

Fragmented care means patients can be put on drugs by many different specialists, says Charles Warlow, while Dr Wendy Outwin highlights the daily reality of prescribing medicines Ministers seem to have found yet another way to bash overburdened GPs (Government review finds 10% of drugs dispensed in England are pointless, 22 September). There is nothing …

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters Read More »

Hetero Labs Limited -Walk-In Interview for Production/ QA/ QC/ Engineering/ R&D On 28th Sept’ 2021 @ Kurnool

Hetero Labs Limited -Walk-In Interview for Production/ QA/ QC/ Engineering/ R&D On 28th Sept’ 2021 @ Kurnool Job Description Greetings from Hetero !!! Hetero -Mega Job Mela We are Hiring M.Sc (Organic Chemistry/ Analytical Chemistry) & B.Sc Chemistry/ B.Com’/  B.A/ ITI Fitter / Diploma Mechanica Freshers @ Hetero Labs Limited Department: Production/ QA/ QC/ Engineering/ R&D Role: : Jr. …

Hetero Labs Limited -Walk-In Interview for Production/ QA/ QC/ Engineering/ R&D On 28th Sept’ 2021 @ Kurnool Read More »

Capricor’s muscle drug data look good, but partner wanted and Phase 3 test needed

Capricor Therapeutics’ cell therapy for Duchenne muscular dystrophy posted encouraging results from a Phase 2 study enrolling 20 patients. But the FDA said a Phase 3 test is needed to support a regulatory submission, and the biotech is hunting for a pharmaceutical industry partner.

Boosters start, even as millions remain unprotected

The U.S. launched a campaign to offer boosters of Pfizer’s COVID-19 vaccine to millions of Americans on Friday even as federal health officials stressed the real problem remains getting first shots to the unvaccinated.

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for R&D / Process R&D On 2nd October 2021

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for R&D / Process R&D On 2nd October 2021 Job Description Dear Candidate, Walk-In Drive On 2nd October 2021 For R&D  (CRO) @ Chemveda Life Sciences, Hyderabad Department: Chemistry Services Designation: Research Chemist/ Sr. Research Chemist/ Research Associate/ SRA Qualification: M.Sc. (Chemistry/ Organic chemistry/ Medicinal Chemistry) Experience: 2-8 years Division: Synthesis Work Location: Hyderabad …

Chemveda Life Sciences Pvt. Ltd- Walk-In Drive for R&D / Process R&D On 2nd October 2021 Read More »

US has enough COVID-19 vaccines for boosters, kids’ shots

With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident there will be enough for both qualified older Americans seeking booster shots and the young children for whom initial vaccines are expected to be approved in the not-too-distant future. The spike in demand — expected following last week’s federal …

US has enough COVID-19 vaccines for boosters, kids’ shots Read More »

More hospitals forced to ration care amid delta surge

Coronavirus patients are flooding and straining hospitals across the U.S., particularly in western states where administrators are put in positions of needing to ration care as their facilities are pushed to their breaking point by the delta variant…

MedCity Pivot Podcast: A startup co-founder on the urgent changes needed in women’s healthcare

The siloed approach to women’s healthcare is one of the main reasons the U.S. is unable to improve its record in this arena, according to Carolyn Witte, co-founder of startup Tia. In our latest episode, she discusses how her company is trying to solve this issue while also working to close the gaps that deepen …

MedCity Pivot Podcast: A startup co-founder on the urgent changes needed in women’s healthcare Read More »

Study: Rural hospitals that merged or were bought saw death rates drop

The mortality rates at rural hospitals for certain conditions, including heart attacks and stroke, decreased in the years following a merger or an acquisition compared with facilities that remained independent, a new study shows. This is a departure from research done on the effects of M&A on urban hospitals.

Intas Pharmaceuticals -Walk-In Interviews for Quality Control On 2nd October 2021

Intas Pharmaceuticals -Walk-In Interviews for Quality Control On 2nd October 2021 Job Description Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world. We have hiring for Quality …

Intas Pharmaceuticals -Walk-In Interviews for Quality Control On 2nd October 2021 Read More »

Confusion reigns over vaccine booster rollout

States are bracing for confusion as the Biden administration begins rolling out booster doses of Pfizer’s COVID-19 vaccine.Chaotic and at times disparate messaging from administration health officials over the past month has culminated in a…

Zydus Cadila-Openings for Regulatory Affairs Department -Apply Now

Zydus Cadila-Openings for Regulatory Affairs Department -Apply Now Job Description Greetings from Zydus Cadila Zydus Cadila -We are recruiting for Vaccine Technology Center. We are looking for people with 12 to 18 years experience in Regulatory Affairs RA -Vaccines & Diagnostics Experience: 10-20 years Those Interested can Share their CV to Rachana.narayan@zyduscadila.com Zydus Cadila-Openings for Regulatory Affairs …

Zydus Cadila-Openings for Regulatory Affairs Department -Apply Now Read More »

Eris Lifesciences Ltd-Urgent Requirements for Production ( OSD)/ Soft gel Production -Apply Now

Eris Lifesciences Ltd-Urgent Requirements for Production ( OSD)/ Soft gel Production -Apply Now Job Description Job Location- Guwahati (Assam) Job Posted date- 25-09-2021 Last Date- 10/10/2021. Production (OSD)- Executive-Granulation Officer, Compression Officer Experience Required for Production OSD Officer- 2 to 4 years Qualification Required-   B. Pharma, M. Pharm. OSD Manufacturing Operator – Capsule Operator, Granulation Operator , Sachet Operator, Soft Gel …

Eris Lifesciences Ltd-Urgent Requirements for Production ( OSD)/ Soft gel Production -Apply Now Read More »

Webinar on Interplay Between FDA Law and Patent Law

Schwegman Lundberg & Woessner will be offering a webinar entitled “Interplay Between FDA Law and Patent Law: Avoiding Indigestion After Belcher v. Hospira” on September 27, 2021 from 12:00 pm to 1:30 pm (CT). Suneel Arora, Timothy Christman, Lea Westman, and John Swart of Schwegman Lundberg & Woessner will discuss the Federal Circuit’s decision in …

Webinar on Interplay Between FDA Law and Patent Law Read More »

Webinar on Inventorship and Assignment

Schwegman Lundberg & Woessner will be offering a webinar entitled “Inventorship and Assignment: Two Vital Concepts in Patent Law” on September 28, 2021 starting at 12:00 pm (CT). Douglas Portnow and Ryan Connell Schwegman Lundberg & Woessner will provide an overview of how inventorship is determined and why assignment is important, including hypotheticals for audience …

Webinar on Inventorship and Assignment Read More »

FCBA Remote Program on Alternative Dispute Resolution

The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled “Mediation Programs and Other Forms of Alternative Dispute Resolution” on September 28, 2021 from 3:00 pm to 4:00 pm (ET). Rory Radding of Mauriel Kapouytian Woods LLP will moderate a panel consisting of Hon. Marian Blank Horn. Judge, U.S. Court of Federal …

FCBA Remote Program on Alternative Dispute Resolution Read More »

Webinar on How USPTO Puts Patent Applications on Hold

IPWatchdog will be offering a webinar entitled “Patent Purgatory: How the USPTO Puts Patent Applications on Hold, and How One Inventor Is Fighting Back” on September 29, 2021 at 12:00 pm (ET). Gene Quinn of IPWatchdog, Inc.; Andrew Grossman of BakerHostetler; Paul Kamenar, Senior Fellow of the Administrative Conference of the United States; and independent …

Webinar on How USPTO Puts Patent Applications on Hold Read More »

BIO IPCC Webinar Series

The Biotechnology Innovation Organization IP Counsels Committee will be offering the next installment of its webinar series on September 29, 2021 at 1:00 pm (EDT). In the webinar, entitled “112 Enablement: What to Watch Out For,” Michael Bunis of Choate Hall & Stewart LLP will moderate a panel consisting of Stephanie Schonewald of Choate Hall …

BIO IPCC Webinar Series Read More »

Webinar on IP Valuation

The International Intellectual Property Law Association (IIPLA) will be offering a live webinar on “IP Valuation” on September 29, 2021 from 10:00 am to 11:00 am (PST). David Wanetick of IncreMental Advantage will provide attendees with the skill set necessary to value patents. Those wishing to register for the webinar can do so here.

FCBA Remote Program on Litigating in Western District of Texas

The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled “How to Litigate in the Western District of Texas” on September 29, 2021 from 4:30 pm to 5:40 pm (ET). Christian Hurt of Davis Firm P.C. will moderate a panel consisting of Hon. Alan D. Albright, District Judge, U.S. District Court for …

FCBA Remote Program on Litigating in Western District of Texas Read More »

USPTO Webinar on China IP

The U.S. Patent and Trademark Office will offer a webinar entitled “China IP: Quarterly Legislation and Case Law Update” on September 30, 2021 from 1:00 pm to 2:00 pm (ET). The webinar, which is the second of a planned series of quarterly updates, will cover the latest developments in intellectual property (IP) law in China. …

USPTO Webinar on China IP Read More »

Hetero Labs Limited-Walk-In Interviews for B.Tech Chemical Freshers On 27th Sept’ 2021

Hetero Labs Limited-Walk-In Interviews for B.Tech Chemical Freshers On 27th Sept’ 2021 Job Description Hetero Labs Ltd is one of the Largest Pharmaceutical Company in India. Hetero conducting Walk in Interview For B.Tech- Chemical Freshers to work in IPQA department in API Manufacturing Unit located in Nakkapally Visakhapatnam. Department: IPQA (In-Process Quality Assurance) Designation :Officer Qualification: B.Tech …

Hetero Labs Limited-Walk-In Interviews for B.Tech Chemical Freshers On 27th Sept’ 2021 Read More »

Dr. Reddy’s Laboratories– Hiring Any Graduate for Area Business Manager -Apply Now

Dr. Reddy’s Laboratories– Hiring Any Graduate for Area Business Manager -Apply Now Job Description Dr. Reddy’s Laboratories– Hiring Any Graduate for Area Business Manager @ Mumbai, Bangalore, Mangalore, Madurai, Kolkata Dear Connections, •We are hiring ABM (Individual Contributions) for Oncology super Specialty. Interested  folks can apply using the below link. •Please like, Comment, and Share for …

Dr. Reddy’s Laboratories– Hiring Any Graduate for Area Business Manager -Apply Now Read More »

Federal appeals court blocks NYC teacher vaccine mandate

A federal appeals court blocked New York City’s coronavirus vaccine mandate late Friday evening, dealing a blow to the city days before the mandate goes into effect. The 2nd Circuit Court of Appeals granted an expedited injunction on Friday…

Federal judge upholds hospital system’s COVID-19 vaccine mandate

A Kentucky federal judge on Friday upheld a hospital system’s COVID-19 vaccine mandate, ruling that the hospital had the authority to issue such a requirement. In a 20-page ruling, U.S. District Judge David Bunning turned down a request from…

Israel says US booster decision vindicates its vaccine strategy

Israel says that the Biden administration’s decision to move forward with coronavirus booster shots vindicates its vaccine strategy.The Food and Drug Administration (FDA) authorized a third dose of Pfizer’s coronavirus vaccine on Wednesday for…

From the FDA’s Empty Seat to Chock-Full ICUs, Journalists Recap the Week’s Stories

KHN correspondent Rachana Pradhan discussed why President Joe Biden hasn’t yet nominated a permanent leader for the Food and Drug Administration on Newsy’s “Morning Rush” on Thursday. Click here to hear Pradhan on “Morning Rush“ Read Pradhan’s “Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief” KHN freelancer Nick Ehli discussed Montana’s …

From the FDA’s Empty Seat to Chock-Full ICUs, Journalists Recap the Week’s Stories Read More »

Rubicon Research-Walk-In Interviews for Freshers & Experienced On 1st Oct’ 2021

Rubicon Research-Walk-In Interviews for Freshers & Experienced On 1st Oct’ 2021 Job Description We are hiring!! Be Part of Rubicon Research’s growth story We have multiple vacancies in our Production Department. Department: Production Designation: Technician / Sr. Technician / D.Pharm Freshers / ITI Freshers Qualification: ITI/ Diploma Location: Ambernath Send your resumes to nilima.bhosale@rubicon.co.in Date : 1st October, 2021 Time: 09:00 AM …

Rubicon Research-Walk-In Interviews for Freshers & Experienced On 1st Oct’ 2021 Read More »

XL Laboratories Pvt. Ltd- (80+ Openings) Walk-In Interviews for QC, Production, QA, IP, FRD, Engineering On 26th Sept’ 2021

XL Laboratories Pvt. Ltd- (80+ Openings) Walk-In Interviews for QC, Production, QA, IP, FRD, Engineering On 26th Sept’ 2021 Job Description XL Laboratories Pvt. Ltd, Bhiwadi Conducting Walk-In Interviews for QC, Production, QA, IP, FRD/ Engineering Department: QC, Production, QA, IP, FRD/ Engineering Experience: 1-12 years Qualification:  M.Sc/ M.Pharm/ B.Pharm/ B.Sc/ ITI/ Diploma/ 10th/ 12th Positions: Officers, Executive, Sr. Executive, Operators, …

XL Laboratories Pvt. Ltd- (80+ Openings) Walk-In Interviews for QC, Production, QA, IP, FRD, Engineering On 26th Sept’ 2021 Read More »

Jubilant Biosys- Walk-In Interviews for Freshers & Experienced On 2nd & 3rd October’ 2021

Jubilant Biosys- Walk-In Interviews for Freshers & Experienced On 2nd & 3rd October’ 2021 Job Description •Walk-In Interviews at Hotel Golden Tulip, Salt Lake, Kolkata On 2nd & 3rd October 2021 (Saturday 7 Sunday) @ Jubilant Biosys, Noida. Apply Here for pre registration: https://lnkd.in/eMJJcWCr Department: Synthesis & Medchem R&D Role: : Research Associate / Sr. Research Associate / …

Jubilant Biosys- Walk-In Interviews for Freshers & Experienced On 2nd & 3rd October’ 2021 Read More »

Satyadivis Pharmaceuticals Pvt. Ltd- Walk-In Interviews for Freshers & experienced On 27th Sept. 2021

Satyadivis Pharmaceuticals Pvt. Ltd- Walk-In Interviews for Freshers & experienced On 27th Sept. 2021 Job Description Walk-In Interviews for Freshers & experienced in Production/ QA/ QC/ Warehouse/ Maintenance @ Satyadivis Pharmaceuticals Pvt. Ltd Walk-In Interview @ Satyadivis Pharmaceuticals Pvt. Ltd. Interviews will be held on 27th September 2021 from 09:00 AM to 01:00 PM Job Location: …

Satyadivis Pharmaceuticals Pvt. Ltd- Walk-In Interviews for Freshers & experienced On 27th Sept. 2021 Read More »

Hetero Labs Limited -Walk-In Interviews for Freshers in Production/ QA/ QC/ Engineering Dept. On 26th Sept’ 2021

Hetero Labs Limited -Walk-In Interviews for Freshers in Production/ QA/ QC/ Engineering Dept. On 26th Sept’ 2021 Job Description Greetings from Hetero !!! We are Hiring M.Sc (Organic Chemistry/ Analytical Chemistry) & B.Sc Chemistry/  ITI Fitter / Diploma Mechanical  Freshers @ Hetero Labs Limited Department: Production/ QA/ QC/ Engineering Role: : Jr. Chemist/ Jr. Officer/ Technician Candidates looking for …

Hetero Labs Limited -Walk-In Interviews for Freshers in Production/ QA/ QC/ Engineering Dept. On 26th Sept’ 2021 Read More »

More behavioral health providers need EHRs, MACPAC says

The Medicaid and the Children’s Health Insurance Program won’t achieve significant progress on its goals if behavioral health providers don’t have the health IT to make it possible, said MACPAC Commissioner Darin Gordon.

Life sciences use of digital twins mirrors its application in other industries

Life sciences companies are using “digital twins” for everything from drug discovery to manufacturing. A panel of experts at MedCity News’ INVEST Digital Health conference discussed how this capability to run virtual simulations is changing practices now while also shaping the industry for the years to come.

How Marketplace Costs and Premiums Will Change if American Rescue Plan Subsidies Expire

In a new Policy Watch, KFF analysts explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for the Affordable Care Act’s health insurance Marketplace federal subsidies. While the COVID-19 relief legislation passed earlier this year provides greater subsidy assistance through 2022, Democrats in Congress are…More

Your weekend reading list

Did COVID-19 affect quality of life valuations? Medication adherence measurement: claims vs. pharmacy fill data. “Patients’ free choice of physicians is not always good” Digital Health funding stats. Academic research on digital health. Impact of hospice care on family costs. Impact of VBID for patients with diabetes. “Being sick is a full-time job”

#Healthin2Point00, Episode 231 | Pager, Ovivia, Meru Health, and NOCD

It’s Telehealth Awareness Week! Today on Health in 2 Point 00, we cover Pager raising $70 million, bringing their total to $132.6 million. German-based company Ovivia gets $80 million, bringing their total to $127 million. Meru Health raises $38 million, and NOCD raises $33 million. —Matthew Holt

Compounding Research

FDA is engaged with the following institutions to conduct research to help inform the public and the agency’s policies regarding compounded drugs

Communication and Collaboration Tools Transform Clinician Workflows

Patient care is one of a nurse’s core skills, but outdated forms of communication can prevent the efficient flow of information needed between clinicians for immediate collaboration. However, the deployment of mobile devices with clinical communication and collaboration (CC&C) capabilities can improve workflows and, ultimately, patient outcomes. These technologies have evolved over time, and their …

Communication and Collaboration Tools Transform Clinician Workflows Read More »

How Marketplace Costs and Premiums will Change if Rescue Plan Subsidies Expire

In this Policy Watch we explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for the Affordable Care Act’s health insurance Marketplace federal subsidies. While the COVID-19 relief legislation passed earlier this year provides greater subsidy assistance through 2022, Democrats in Congress are currently considering …

How Marketplace Costs and Premiums will Change if Rescue Plan Subsidies Expire Read More »

Payers and the ABCs of digital literacy

With the growing adoption of new digital technologies to improve patient care, comes the need to demonstrate their benefits to all stakeholders, including payers. Showing that patients and HCPs understand, can use and benefit from digital elements is an important but arguably under addressed aspect of securing reimbursement for them. By putting patients at the …

Payers and the ABCs of digital literacy Read More »

Sunscreen: How to Help Protect Your Skin from the Sun

Some sun safety tips: limit time in sun, wear clothing to cover skin exposed to the sun, use broad spectrum sunscreens with SPF values of 15 or higher regularly and as directed, reapply sunscreen at least every two hours, and more often if you’re sweating or jumping in and out of the water.

France, Germany nominate WHO chief for second term

France and Germany nominated World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus for a second term on Thursday.“Today September 23rd, France and Germany, in coordination with a group of EU states, nominated Dr Tedros Adhanom…

Biden urges all eligible Americans to get a booster shot

President Biden on Friday urged older Americans, frontline workers, and those with underlying health conditions who received a Pfizer coronavirus vaccine between January and March to get a booster shot.”This week, as planned, we took a key step in…

PharmaShots Weekly Snapshots (September 20 – 24, 2021)

Everest’s SPR206 Receives the NMPA’s IND Approval for the Treatment of MDR Gram-Negative Bacterial Infections Published: Sept 24, 2021 | Tags: Everest, SPR206, NMPA, IND, Approval, MDR Gram-Negative Bacterial Infections GE Healthcare to Acquire BK Medical for ~ $1.45B Published: Sept 24, 2021 | Tags: GE Healthcare, Acquire, BK Medical, ~ $1.45B Roche Presents Results …

PharmaShots Weekly Snapshots (September 20 – 24, 2021) Read More »

Research Results Published: More Apps are Integrating with EHRs

New ONC research shows a more than 20% rise in the number of apps that integrate with certified electronic health records (EHRs). A manuscript highlighting the findings of this research was recently published in the Journal of the American Medical Informatics Association: “The Ecosystem of Apps and Software integrated with Certified Health Information Technology”. Our …

Research Results Published: More Apps are Integrating with EHRs Read More »

Walensky goes against CDC panel to endorse boosters for healthcare workers

The panel had offered the option of a booster for those ages 18 to 49 who have chronic health problems and want one. But the advisers refused to go further and open boosters to otherwise healthy front-line health care workers who aren’t at risk of severe illness but want to avoid even a mild infection.

Alabama leading US in COVID-19 death rate over last week

The increase in deaths come as hospitalizations in the state fell below 1,800 patients for the first time in a month, a change health officials said likely was due to both people getting well and dying.

A daily pill to treat COVID could be just months away

At least three promising antivirals for COVID are being tested in clinical trials, with results expected as soon as late fall or winter, said Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, who is overseeing antiviral development.

Shilpa Medicare Limited-Walk-In Interviews for Executive/ Senior Executive On 26th Sept’ 2021

Shilpa Medicare Limited-Walk-In Interviews for Executive/ Senior Executive On 26th Sept’ 2021 Job description: Executive / Senior Executive -Analytical Services Experience: 2-6 years Openings: 05 Job Location: Nacharam, Hyderabad JD: The candidate should have the knowledge and experience in on Analytical method validation, method transfer and method equivalency analysis as per ICH guidelines. The candidates should have the …

Shilpa Medicare Limited-Walk-In Interviews for Executive/ Senior Executive On 26th Sept’ 2021 Read More »

Científicos dicen que una píldora diaria para tratar covid estaría a meses de distancia

Un día después de dar positivo para covid-19 en junio, Miranda Kelly estaba lo suficientemente enferma como para asustarse. Con 44 años, hipertensión y diabetes, la asistente de enfermería tenía problemas para respirar, síntoma lo suficientemente grave como para terminar en la sala de emergencias. Cuando su esposo, Joe, de 46, también se enfermó con …

Científicos dicen que una píldora diaria para tratar covid estaría a meses de distancia Read More »

WHO recommends antibody treatment for some COVID-19 patients

The World Health Organization has recommended that an antibody treatment be used for some COVID-19 patients in an update to its coronavirus treatment guidelines.The recommendation, issued on Friday and based off of experimental trials, encourages…

Everest’s SPR206 Receives the NMPA’s IND Approval for the Treatment of MDR Gram-Negative Bacterial Infections

Shots: The NMPA has approved the IND application of SPR206 (IV) for the treatment of MDR gram-negative bacterial infections. Everest will initiate the clinical program in China & results from the P-I study is expected in 2022 Everest got exclusive rights to develop, manufacture & commercialize SPR206 in China, South Korea, and Southeast Asian countries …

Everest’s SPR206 Receives the NMPA’s IND Approval for the Treatment of MDR Gram-Negative Bacterial Infections Read More »

Early detection of cancers will require blood sweat and tears

An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell. The announcement that the NHS is taking part in a major new clinical trial for a blood test that could detect more than 50 cancers early has been welcomed as a …

Early detection of cancers will require blood sweat and tears Read More »

GE Healthcare to Acquire BK Medical for ~ $1.45B

Shots: GE has signed an agreement to acquire BK Medical for $1.45B in cash and is eligible to receive a high-single-digit return on invested capital within 5yrs. The transaction is expected to close in 2022 The acquisition will allow GE Healthcare to expand its $3B ultrasound business from diagnostics into surgical & therapeutic interventions. The …

GE Healthcare to Acquire BK Medical for ~ $1.45B Read More »

CDC director partially overrules panel, signs off on boosters

Booster doses of Pfizer-BioNTech’s coronavirus vaccine can be administered to potentially tens of millions of people, after the director of the Centers for Disease Control and Prevention early Friday morning overruled recommendations from a key…

Roche builds evidence for Evrysdi’s benefits younger SMA patients

Roche has highlighted new data with its oral treatment for spinal muscular atrophy (SMA) – Evrysdi – showing its benefits when given to pre-symptomatic babies with the rare disease. The updated results come from the open-label RAINBOWFISH study, which investigate the effects of Evrysdi (risdiplam) in children from birth to six weeks who had yet …

Roche builds evidence for Evrysdi’s benefits younger SMA patients Read More »

Roche Presents Results of Evrysdi (risdiplam) in RAINBOWFISH Study for the Treatment of Neuromuscular Disorder at WMS 2021

Shots: The RAINBOWFISH study evaluates the efficacy and safety of Evrysdi in babies aged birth to 6wks. with pre-symptomatic SMA The results showed that 4 out of 5 patients treated with Evrysdi for 12 mos. were able to stand & walk independently within the WHO windows for healthy children. Additionally, all five infants maintained the …

Roche Presents Results of Evrysdi (risdiplam) in RAINBOWFISH Study for the Treatment of Neuromuscular Disorder at WMS 2021 Read More »

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the IgA Nephropathy Market Share Growth

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. Factors such as population aging, lifestyle-modifiable risk factors, a decline in early-life infectious diseases, sedentary lifestyle, unhealthy food habits have resulted in the emergence of chronic diseases as a major global health threat. Among CDs, Chronic kidney disease (CKD) is particularly of …

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the IgA Nephropathy Market Share Growth Read More »

PROpel study backs Lynparza combo in first-line prostate cancer

AstraZeneca and Merck & Co PARP inhibitor Lynparza is already used to treat prostate cancer associated with a specific genetic mutation, but could see the drug’s use broadened after a positive phase 3 trial. The results of the PROpel study showed that a combination of Lynparza (olaparib) and Johnson & Johnson’s hormonal therapy Zytiga (abiraterone …

PROpel study backs Lynparza combo in first-line prostate cancer Read More »

Lawmakers say Biden must do more on global vaccines

President Biden is facing calls from lawmakers and advocates to go farther in helping vaccinate the world against COVID-19, even after pledging an additional 500 million doses at a summit on Wednesday.The additional 500 million Pfizer doses for the…

Contact-tracing apps ‘could improve COVID vaccination strategy’

Targeting people for COVID-19 vaccination using contract-tracing apps could be a shortcut to achieving herd immunity in the population using fewer doses, according to Canadian researchers. According to Mark Penney, Yigit Yargic and colleagues from the Perimeter Institute for Theoretical Physics in Ontario, targeting vaccines to people who have more exposure than others is the …

Contact-tracing apps ‘could improve COVID vaccination strategy’ Read More »

Mounting Covid Deaths Fuel School Bus Drivers’ Fears

GRIFFIN, Ga. — Natalia D’Angelo got sick right after school started in August. She was driving a school bus for special education students in Griffin-Spalding County School System about 40 miles south of Atlanta and contracted covid-19. One of her three sons, Julian Rodriguez-D’Angelo, said his mother, who was not vaccinated against the covid virus, …

Mounting Covid Deaths Fuel School Bus Drivers’ Fears Read More »

A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room. When her husband, Joe, 46, fell ill with the virus, …

A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say Read More »

Low Wages and Pandemic Gut Staffing Support for Those With Disabilities

Ernestine “Erma” Bryant likes her job, but the pay is a problem. She works in a caregiver role as a “direct support professional” in Tifton, Georgia, helping people who have intellectual and developmental disabilities with basic functions such as dressing, bathing and eating. Bryant said it’s fulfilling work. “You can help people be successful — …

Low Wages and Pandemic Gut Staffing Support for Those With Disabilities Read More »

Australia shores up Pfizer supply after days of uncertainty

John Frewen says company advised the government on Friday they would deliver the full 9m doses in October Australia will get its full supply of Pfizer next month, with the head of the country’s rollout saying the company had confirmed it would provide 9m doses in October as planned. After days of uncertainty over Pfizer …

Australia shores up Pfizer supply after days of uncertainty Read More »

CDC overrules its advisors, backing COVID booster for health workers

The Centre for Disease Control and Prevention (CDC) in the US has backed booster doses of Pfizer and BioNTech’s COVID-19 vaccine Comirnaty in line with its recent FDA approval, overruling the advice of its own expert advisors. The CDC’s Advisory Committee on Immunisation Practices (ACIP) voted unanimously yesterday to recommend a third dose of Comirnaty …

CDC overrules its advisors, backing COVID booster for health workers Read More »

Pfizer and BioNTech’s COVID-19 Vaccine Booster Receive the US FDA’s EUA for the Treatment of COVID-19

Shots: The US FDA has issued a EUA for the COVID-19 booster vaccine (administered at least 6mos. after completion of primary 2 doses) to prevent COVID-19 in individuals aged ≥65yrs. & 18 through 64yrs. of age who at high risk of severe COVID-19 The EUA is based on clinical data that showed higher neutralizing Ab …

Pfizer and BioNTech’s COVID-19 Vaccine Booster Receive the US FDA’s EUA for the Treatment of COVID-19 Read More »

INTCR 2021 winners announced

The winners of the 2021 International Clinical Researcher have been announced, find out who emerged victorious.

Innovent Reports the First Patient Dosing in P-II CIBI112A201 Trial of IBI112 for the Treatment of Plaque Psoriasis

Shots: The first patient has been dosed in P-II CIBI112A201 clinical trial evaluating IBI112 (SC, anti-IL-23p19 mAb) in patients with moderate-to-severe PsO The primary objective of the study is to evaluate the efficacy of IBI112 at different doses. The safety of drugs & difference of administration interval b/w the different therapeutic regimens will also be …

Innovent Reports the First Patient Dosing in P-II CIBI112A201 Trial of IBI112 for the Treatment of Plaque Psoriasis Read More »

Identifying KOLs in Growing and Emerging Markets

The process of discovering HCPs who are leading key opinion leaders (KOLs) in emerging and growing markets is not as straightforward as it is in other countries. When identifying KOLs within emerging markets, the need to conduct solid, primary research becomes paramount.  Relying solely on the typical quantitative methodologies such as examining publications, citations, clinical …

Identifying KOLs in Growing and Emerging Markets Read More »

Hy-Gro Chemicals Pharmtek Pvt. Ltd.-Walk-In Interviews for Production On 25th Sept’ 2021

Hy-Gro Chemicals Pharmtek Pvt. Ltd.-Walk-In Interviews for Production On 25th Sept’ 2021 Job Description Department: Production Positions: Jr. Chemists to Sr. Chemists Qualification: B.Sc, B.Tech, M.Sc Experience: 2-5 years Location: Bollaram, Hyderabad Date: 25th September 2021 Time: 10:00 AM to 2:00 PM Venue:  Unit -I Bollaram, Hy-Gro Chemicals Pharmtek Pvt. Ltd., # 203 & 204, 2nd Floor, Ashoka Bhoopal Chambers, Sardar Patel Road, …

Hy-Gro Chemicals Pharmtek Pvt. Ltd.-Walk-In Interviews for Production On 25th Sept’ 2021 Read More »

AstraZeneca Collaborates with VaxEquity to Develop and Commercialize Self-Amplifying RNA Therapeutics

Shots: VaxEquity can receive ~$195M in development, approval, and sales-based milestones along with royalties per program & is also eligible to receive an equity investment from AstraZeneca for the development of the saRNA platform The focus of the collaboration is to optimize and validate VaxEquity’s saRNA platform to advance novel therapeutic programs AstraZeneca support VaxEquity …

AstraZeneca Collaborates with VaxEquity to Develop and Commercialize Self-Amplifying RNA Therapeutics Read More »

Multi-tip Punches Impact on Compression Forces v2

Reviews critical stages of rotary tablet press process, describes impact of multi-tip punches, and how to overcome common challenges in the tablet compression industry

SDOH Strategies All Provider Organizations Should be Adopting Now

Joe Nicholson, III, DO, Chief Medical Officer, CareAllies There is growing concern among many well-respected providers about the consequences of fewer preventive services over the past 1½ years as a result of the COVID-19 pandemic. As patients slowly start to resume care throughout 2021 and into 2022, experts predict we will see a spike in …

SDOH Strategies All Provider Organizations Should be Adopting Now Read More »

Hetero Labs Limited -Walk-In Interviews for Quality Control Department On 25th Sept’ 2021

Hetero Labs Limited -Walk-In Interviews for Quality Control Department On 25th Sept’ 2021 Job Description Greetings for the day from Hetero !!! We  are hiring for the positions Jr. Officer/ Officer/ Executive in Quality Control Department: Quality Control Designation: Jr. Officer/ Officer/ Executive Qualification: B.Pharm/ M.Sc/ M.Pharm Experience: 1-5 years Location: Hyderabad (Unit -III) Those who are Unable to Attend the Interview …

Hetero Labs Limited -Walk-In Interviews for Quality Control Department On 25th Sept’ 2021 Read More »

Sun Pharmaceuticals Pvt. Ltd-Walk In Drive for Multiple Positions On 26th September 2021

Sun Pharmaceuticals Pvt. Ltd-Walk In Drive for Multiple Positions On 26th September 2021 Job Description  Walk In Drive for Multiple Positions in Production/ QA/ QC/ QC-Micro Department @ Sun Pharmaceuticals Pvt. Ltd Department: Production/ QA/ QC/ QC-Micro Designation: Technician/ Officer/ Sr. Officer Qualification: B.Sc/ B.Pharm/ Diploma/ M.Sc/ M.Pharm/ ITI/ D.Pharm Experience: 1-6 years Location: Halol, Vadodara Date: 26th September 2021 Time: 09:00 AM to …

Sun Pharmaceuticals Pvt. Ltd-Walk In Drive for Multiple Positions On 26th September 2021 Read More »

Remote patient monitoring use is on the rise, but reimbursement needs to catch up

The reimbursement model for remote patient monitoring needs to evolve as it may be holding providers back from investing in these programs, according to panelists at the MedCity INVEST Digital Health conference. Key issues with the structure as it stands now include the fact that there are too many gray areas that result in claims …

Remote patient monitoring use is on the rise, but reimbursement needs to catch up Read More »

EU-OSHA celebrates multilingualism to mark the European Day of Languages

24/09/2021 EU-OSHA celebrates multilingualism to mark the European Day of Languages source: https://www.coe.int/ Europe’s multilingualism represents a tool for achieving greater intercultural understanding and a key element in the rich cultural heritage of the continent. Therefore, every 26 September marks the European Day of Languages, an inititiative of the Council of Europe together with the …

EU-OSHA celebrates multilingualism to mark the European Day of Languages Read More »

Abortion providers again ask Supreme Court to intervene in Texas case

Abortion providers on Thursday turned to the Supreme Court to ask the justices again to intervene in a legal challenge over the new Texas abortion law, even as the case proceeds through a lower court.The request was somewhat unusual, coming just…